Towards precision medicine for brain arteriovenous malformations
Journal of Clinical Investigation · 15.05.2026 · 136 (10)
DOI: 10.1172/jci205086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.05.2026. Verfasst von Andrew T Hale und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Intracranial Arteriovenous Malformations, Precision Medicine, Mutation. Die Arbeit nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Recent advances in cerebrovascular genomics, single-cell biology, pharmacology, and gene editing technology are transforming our understanding of brain arteriovenous malformations (bAVMs) — a leading cause of pediatric hemorrhagic stroke. Once considered static anatomical defects, bAVMs are now recognized as dynamic, genetically driven lesions resulting from somatic mutations in KRAS , BRAF , and pathways involved in arteriovenous specification, angiogenesis, and vascular remodeling. By integrating human genetics, animal models, and endovascular innovations, researchers have uncovered convergent mechanisms that link endothelial Ras/MAPK hyperactivation to abnormal vessel growth and higher rupture risk. These insights provide a foundation for precision medicine approaches that combine molecular diagnostics — such as liquid or endoluminal biopsies — with mutation-specific pharmacotherapies and emerging CRISPR-based gene editing strategies. We suggest that genotype-guided interventions, tailored by spatial and developmental cerebrovascular context, could ultimately reclassify bAVMs from surgically incurable malformations to treatable molecular conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
- Division of Neurosurgery, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Neurosurgery, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, USA.
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
Zitieren
APA
Hale, A. T., Kundishora, A. J., Kalailingam, P., Barak, T., Duy, P. Q., Ramundo, C. M., Fan, B., Li, Q., Brastianos, P. K., Shankar, G. M., Alper, S. L., Kleinstiver, B. P., Musolino, P. L., & Kahle, K. T. (2026). Towards precision medicine for brain arteriovenous malformations. Journal of Clinical Investigation, 136(10). https://doi.org/10.1172/jci205086
Vancouver
Hale AT, Kundishora AJ, Kalailingam P, Barak T, Duy PQ, Ramundo CM, et al. Towards precision medicine for brain arteriovenous malformations. Journal of Clinical Investigation. 2026;136(10). doi:10.1172/jci205086
BibTeX
@article{Hale2026,
author = {Hale, Andrew T and Kundishora, Adam J and Kalailingam, Pazhanichamy and Barak, Tanyeri and Duy, Phan Q and Ramundo, Christopher M and Fan, Baojian and Li, Qiang and Brastianos, Priscilla K and Shankar, Ganesh M and Alper, Seth L and Kleinstiver, Benjamin P and Musolino, Patricia L and Kahle, Kristopher T},
title = {Towards precision medicine for brain arteriovenous malformations},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {10},
doi = {10.1172/jci205086}
}
EUVIMED